COMPANY FACTS

Cromos Pharma’s mission is to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.

COMPANY FACTS

Cromos Pharma’s mission is to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.

2023
Cromos Pharma Contemplates Complex International GMO Research Program Regulations
Cromos Pharma Contemplates Complex International GMO Research Program Regulations
Cromos Pharma achieves a significant milestone as Georgia approves its inaugural GMO clinical trial, marking a notable advancement in the country's medical research sector. This pioneering accomplishment not only underscores the company's commitment to scientific advancement but also prompts a comprehensive reflection on the intricate regulatory landscape governing GMO trials in the US and EU.
Read more 2023
Cromos Pharma Completes a 10-country EU Clinical Trial Submission via CTIS
Cromos Pharma Completes a 10-country EU Clinical Trial Submission via CTIS
Cromos Pharma is proud to announce the successful completion of its largest EU submission to date via the Clinical Trials Information System (CTIS). Our team expertly navigated the submission process, delivering comprehensive dossiers for both Part 1 and Part 2 across 10 countries. As we continue to master this new regulatory paradigm, we are excited to assist more clients in launching their clinical trials in the EU.
2023
Cromos Pharma Launches an Ulcerative Colitis Clinical Trial in Türkiye
Cromos Pharma Launches an Ulcerative Colitis Clinical Trial in Türkiye
Cromos Pharma has launched a late phase clinical trial on Ulcerative Colitis in Türkiye, aiming to explore innovative treatments for this challenging condition. The company successfully engaged with key opinion leaders in the field, ensuring comprehensive expertise is applied to the study. This represents an important step for Cromos Pharma as it expands its presence into Türkiye, opening doors for future endeavors.
2023
2022
new countries
OFFICES IN TÜRKIYE, KAZAKHSTAN AND SERBIA
Cromos Pharma is strengthening its presence in Türkiye, Kazakhstan and Serbia by establishing local legal entities, opening full-scale offices, and increasing the local staff presence. 
Read more 2022
2021
clinical trials in central & easter europe, Company facts,
10,000 PATIENTS ENROLLED IN ONCOLOGY STUDIES
In 2021, Cromos Pharma achieved an important milestone as it reached 10,000 patients enrolled in its oncological studies. Cromos Pharma also managed its first trial investigating a vaccine for COVID-19.
2021
2020
clinical trials in central & easter europe, Company facts,
CLINICAL TRIALS DURING COVID-19
The COVID-19 pandemic dominated 2020. Cromos Pharma was proud to play its part in the fight against the virus by managing its first global clinical trial of a drug to treat severe COVID-19 infection. Throughout 2020, Cromos Pharma continued to manage successful clinical trials related to COVID-19 as well as a wide-range of other therapeutic areas.
2020
2019
krakow, poland, clinical trials in poland
OFFICE IN POLAND
The opening of the new office strengthened Cromos Pharma’s position in Poland where it has been operational since 2015.
2019
2018
UK Flag, clinical trials in central & easter europe
OPERATIONS IN NORTH AMERICA
With a new clinical operations base in South Florida, Cromos™ Pharma is poised to better serve US and international clients who seek FDA approval and access to North, Central and South America.
2018
2017
Cromos Pharma begins operations in Kazakhstan
OPERATIONS IN KAZAKHSTAN
Cromos™ Pharma launched its first clinical trial in Kazakhstan, an emerging clinical trial destination in Central Asia.
Read more 2017
2016
Best clinical research organization in US, Centra & eastern Europe
LAUNCH OF REFERRAL SITE NETWORK
By analyzing study population, sites’ motivation to enroll, type of disease, subjects’ barriers to participation in the studies, we developed a comprehensive system of recruitment optimization.
Read more 2016
clinical trials in central & easter europe, Company facts,
OFFICE IN HUNGARY
Further geographic expansion included opening a representative office in Budapest, Hungary.
Read more 2016
armenia, clinical trials in armenia
OPERATIONS IN ARMENIA
Cromos™ Pharma started to provide clinical trials services in Armenia, an unsaturated area for clinical research.
2016
2015
clinical trials in romania, clinical research organization in romania
OPERATIONS IN ROMANIA
Cromos™ Pharma's European presence expanded further with the starting of operations in Romania.
2015
clinical trials in czech republic
OFFICE IN CZECH REPUBLIC
Successful initiation of two studies in Czech Republic led to the opening of an office in Prague.
Read more 2015
krakow, poland, clinical trials in poland
OPERATIONS IN POLAND
The start of operations in Poland allowed Cromos™ Pharma to enter one of the most prominent Eastern European clinical trials markets.
2015
2014
Flag, clinical trials in central & easter europe, Company facts,
OPERATIONS IN ISRAEL
Initiation of operations in Israel allow Cromos™ Pharma to expand its capabilities in running cutting-edge pharmaceutical and medical device trials.
Read more 2014
clinical trials in bulgaria
OPERATIONS IN BULGARIA
Continuing Cromos™ Pharma's strategy for geographical expansion, operations in Bulgaria were started with an arterial hypertension trial.
2014
clinical trials in ukraine
OPERATIONS IN SLOVAKIA
Including Slovak sites into an international phase III study in NSCLC marked the beginning of Cromos™ Pharma's high grade operations in this country.
2014
clinical trials in czech republic
OPERATIONS IN CZECH REPUBLIC
Cromos™ Pharma announced the launch of operations in Czech Republic.
2014
2013
clinical trials in belarus
OPERATIONS IN BELARUS
Cromos™ Pharma continued to expand its geography and started operations in Belarus with a successful international multi-centre trial in patients with angina pectoris.
Read more 2013
us-based clinical research organization in central & eastern europe
EU HQ ESTABLISHED IN IRELAND
Cromos™ Pharma's EU Headquarters established in Dublin, Ireland, as part of the company's further growth strategy in EU market.
2013
clinical trials in georgia
OFFICE IN GEORGIA
Cromos™ Pharma opened an office in the capital city of Tbilisi and started to provide full service support for clinical trials in Georgia.
Read more 2013
clinical trials in moldova
OPERATIONS IN MOLDOVA
Cromos™ Pharma initiated operations in Moldova.
2013
2011
clinical trials in russia, clinical research organization in russia
SECOND OFFICE IN RUSSIA (SMOLENSK)
After several steady years of expansion the second office in Russia in the city of Smolensk was established.
2011
clinical trials in estonia, clinical research organization in estonia
OPERATIONS IN ESTONIA
Cromos™ Pharma started operations in Estonia by successfully participating in an international multi-centre study in chronic heart failure.
2011
2010
clinical trials in Lithuania, clinical research organization in Lithuania
OPERATIONS IN LITHUANIA
Cromos™ Pharma continued to strengthen its market presence by starting activities in Lithuania.
2010
clinical trials in central & easter europe, Company facts,
OPERATIONS IN LATVIA
Cromos™ Pharma started operations in Latvia with initiation of studies in dermatology.
2010
2008
Cromos™ Pharma attends the 1st Kiev Clinical Research Forum
OFFICE IN UKRAINE
After two years of successful growth of operations in Ukraine Cromos™ Pharma opened an office and registered a local legal entity.
2008
2006
US-based clinical research organisation,
OFFICE IN RUSSIA (MOSCOW)
Cromos™ Pharma office opened in Moscow, Russia.
2006
clinical research organization in Ukraine, clinical trials in Ukraine
OPERATIONS IN UKRAINE
Soon after beginning operations in Russia, Cromos™ Pharma added operations in Ukraine.
2006
2004
Portland, clinical trials in central & easter europe,
CROMOS™ PHARMA FOUNDED
Cromos™ Pharma was founded in 2004 in Portland, Oregon, USA.
2004

more about us